|
|
CD40LG triplication associates with immune dysregulation and exhaustion |
|---|---|
| Author: | Santaniemi, Wenny1; Pernaa, Nora1; Glumoff, Virpi1; |
| Organizations: |
1Research Unit of Biomedicine, University of Oulu, Oulu, Finland 2Infectious Diseases Clinic, Oulu University Hospital, Oulu, Finland 3Department of Clinical Genetics, PEDEGO Research Unit, Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland |
| Format: | article |
| Version: | accepted version |
| Access: | embargoed |
| Persistent link: | http://urn.fi/urn:nbn:fi-fe202301051558 |
| Language: | English |
| Published: |
Springer Nature,
2023
|
| Publish Date: | 2023-11-08 |
| Series: |
Journal of clinical immunology |
| ISSN: | 0271-9142 |
| ISSN-E: | 1573-2592 |
| ISSN-L: | 0271-9142 |
| Volume: | 43 |
| Pages: | 323 - 326 |
| DOI: | 10.1007/s10875-022-01392-5 |
| OADOI: | https://oadoi.org/10.1007/s10875-022-01392-5 |
| Type of Publication: |
A1 Journal article – refereed |
| Field of Science: |
3121 General medicine, internal medicine and other clinical medicine 3111 Biomedicine 1184 Genetics, developmental biology, physiology |
| Subjects: | |
| Funding: |
This study was supported by Oulu University Hospital VTR. |
| Copyright information: |
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: https://doi.org/10.1007/s10875-022-01392-5 |